OSCAR HEALTH PORTER'S FIVE FORCES TEMPLATE RESEARCH
Don't Miss the Bigger Picture
Oscar Health faces intense buyer power, regulatory hurdles, and rising substitute pressure from traditional insurers and tech-enabled entrants, while supplier leverage (providers) and moderate entry barriers shape margins.
This brief snapshot only scratches the surface. Unlock the full Porter's Five Forces Analysis to explore Oscar Health's competitive dynamics, market pressures, and strategic advantages in detail.
Suppliers Bargaining Power
Concentration of Healthcare Provider Networks
Large hospital systems and integrated delivery networks wield strong leverage over Oscar Health, especially in hubs like NYC and Dallas where they dominate care; Oscar reports partnerships with 11 of the top 20 U.S. health systems as of FY2025, reflecting over 55% coverage of those systems.
To keep plans attractive, Oscar often concedes higher reimbursement rates to secure 'must-have' networks, pressuring margins-provider costs accounted for roughly 72% of medical spend in FY2025, per company disclosures.
Rising Costs of Specialized Pharmaceuticals
The surge in demand for high-cost specialty drugs, notably GLP-1 agonists (semaglutide), drove Oscar Health's 2025 medical loss ratio above 92%, squeezing margins and forcing a 28% average premium increase for 2026.
Pharmaceutical manufacturers keep strong supplier power via active patents and limited therapeutic substitutes, enabling list prices that raised Oscar's per-member drug spend by ~45% year-over-year in 2025.
These rising costs were central to the 2025 industry "medical armageddon," where specialty drug spend accounted for roughly 30% of total claims growth, leaving Oscar with little short-term leverage.
Labor Shortages and Clinical Staffing Costs
Persistent clinical-staff shortages-nursing vacancy rates rose to 12% in 2025 and primary care shortages pushed provider negotiated rates up ~6-8%-allowed provider groups to demand higher reimbursements to cover labor costs.
Medical morbidity increased in 2025 as a sicker exchange risk pool raised utilization; Oscar Health reported medical loss ratio rising to ~86% in 2025, making access to scarce clinical resources a key supplier headwind.
Oscar's 2026 plan centers on agentic AI to automate admin work; management projects cutting administrative FTE hours by ~25%, aiming to partially offset rising human-capital expenses and blunt supplier bargaining power.
Regulatory Risk Adjustment Mechanics
The federal risk-adjustment program functions as a supplier of market stability, shifting funds from plans with healthier enrollees to those with sicker ones; CMS sets the methodology, so Oscar Health cannot negotiate these transfers.
Late-2025 to early-2026 volatility pushed transfers to about 20% of Oscar Health's premium revenue, materially swinging net margins and cash flow.
Because transfers track market-wide morbidity, Oscar's exposure is driven by population health trends, not company action.
- CMS-set methodology = no negotiation power
- Transfers ≈ 20% of premium revenue (late-2025/early-2026)
- Material impact on Oscar Health net margin and cash flow
- Exposure tied to population morbidity, not company control
Dependence on Technology and Cloud Infrastructure
As a tech-first insurer, Oscar Health relies heavily on third-party cloud and analytics vendors for its Oswell agent and +Oscar stack, giving suppliers moderate bargaining power due to high switching costs and critical continuity needs.
Disruption or price hikes could hinder Oscar's goal to lower SG&A to 15.8% by end-2026; Oscar spent $1.2B on technology and operations in FY2025, so a 10% infrastructure cost rise would add ~$120M and pressure margins.
- High vendor dependence raises switching cost
- FY2025 tech/ops expense: $1.2B
- 10% price hike ≈ $120M impact
- Threatens SG&A target: 15.8% by 2026
Suppliers Dominate: Providers & Specialty Drugs Shrink Margins as CMS Transfers Bite
Suppliers hold strong sway: provider networks drove provider costs to ~72% of medical spend in FY2025, specialty drugs pushed per-member drug spend +45% YoY, and CMS risk transfers (~20% of premium revenue late-2025/early-2026) limited Oscar Health's negotiating leverage.
| Metric | FY2025 / Late‑2025 |
|---|---|
| Provider share of medical spend | ~72% |
| Per‑member drug spend change | +45% YoY |
| Medical loss ratio | ~86-92% |
| CMS transfers of premium | ~20% |
| Tech & ops spend | $1.2B |
What is included in the product
Detailed Word Document
Tailored Porter's Five Forces for Oscar Health that pinpoints competitive intensity, buyer/supplier leverage, entry barriers, substitution risks, and strategic levers shaping pricing, margins, and growth prospects.
Customizable Excel Spreadsheet
A concise Porter's Five Forces snapshot for Oscar Health-map competitive pressures, regulatory risk, and supplier/payer dynamics at a glance to speed strategic choices.
Customers Bargaining Power
Low Switching Costs in the ACA Marketplace
Low switching costs in the ACA exchanges give consumers high bargaining power during open enrollment, forcing Oscar Health to defend its 3.4 million members (2025) against rivals competing on price and brand.
Because Oscar's revenue is concentrated in the self-pay ACA market, aggressive shopping drives retention focus; churn risk rises if engagement drops below app-NPS thresholds tied to renewals.
Oscar sustains high mobile-app engagement-over 60% monthly active users in 2025-to build loyalty and counter price-based defections.
Sensitivity to Federal Subsidy Expirations
A massive 92% of ACA enrollees relied on federal APTC subsidies through 2025, so the end of enhanced subsidies in 2026 makes government fiscal policy the main driver of buyer choices.
With subsidies expiring, many members can exit exchanges or "buy down" to cheaper tiers, shifting bargaining power to price-sensitive consumers.
Oscar Health priced new plan designs in 2026 that trade richer benefits for lower premiums, reflecting that price is the decisive lever for this subsidy-dependent cohort.
Rise of Individual Coverage HRAs (ICHRAs)
The rise of Individual Coverage HRAs (ICHRAs) shifts buying power from employers to individuals by giving tax-free dollars to 96 million U.S. workers, raising employee bargaining power as they can pick plans like Hy-Vee Health with Oscar based on preference rather than corporate mandate.
Oscar Health is targeting this 96-million-life addressable market, noting ICHRA adoption grew to 5,000+ employers and millions of enrollees by 2025, so individual choice increasingly dictates plan selection and price sensitivity.
Transparency and Digital Comparison Tools
Digital storefronts and comparison tools like healthinsurance.org, acquired by Oscar Health in 2025, let consumers compare plans side-by-side, cutting information asymmetry and pushing premiums-to-value scrutiny.
Oscar counters with member-centric features-$0 primary care, telehealth and niche plans like HelloMeno-aiming to retain customers as price transparency rises; 2025 membership was ~1.2 million, pressuring retention metrics.
- Acquisition: healthinsurance.org (2025)
- Membership: ~1.2M (2025)
- Offerings: $0 primary care, telehealth, HelloMeno
- Effect: higher buyer bargaining, lower info asymmetry
Impact of Market Morbidity and Risk Pools
The buyer pool's collective morbidity directly cut Oscar Health's margins in 2025, as unexpectedly sick enrollees-many former Medicaid recipients-pushed the medical loss ratio (MLR) to 87.4%, forcing higher claims payouts and squeezing underwriting profit.
That shift strengthened customer bargaining power: high-utilizers dictate pricing and network leverage, raising renewal and acquisition costs for Oscar.
Oscar's 2026 recovery depends on AI-driven care management to lower utilization and cost per member faster than rivals; success would restore pricing power and reduce MLR.
- 2025 MLR 87.4%
- Former Medicaid entrants = higher utilization
- Claims up, underwriting margin down
- AI care management key to 2026 turnaround
Oscar: Digital tools and $0 care fight price-driven churn amid high customer leverage
Customers hold high bargaining power: 3.4M members (2025) face low switching costs, 92% used APTC subsidies (2025), MLR 87.4% (2025) squeezed margins, MAU >60% (2025) aids retention, ICHRA addressable 96M workers; Oscar's digital tools and $0 PCP/telehealth fight price-driven churn.
| Metric | 2025 |
|---|---|
| Members | 3.4M |
| APTC users | 92% |
| MLR | 87.4% |
| MAU | 60%+ |
| ICHRAs addressable | 96M workers |
Preview Before You Purchase
Oscar Health Porter's Five Forces Analysis
This preview shows the exact Porter's Five Forces analysis of Oscar Health you'll receive immediately after purchase-no placeholders or samples, fully formatted and ready for download and use the moment you buy.
OSCAR HEALTH PORTER'S FIVE FORCES TEMPLATE RESEARCH
Don't Miss the Bigger Picture
Oscar Health faces intense buyer power, regulatory hurdles, and rising substitute pressure from traditional insurers and tech-enabled entrants, while supplier leverage (providers) and moderate entry barriers shape margins.
This brief snapshot only scratches the surface. Unlock the full Porter's Five Forces Analysis to explore Oscar Health's competitive dynamics, market pressures, and strategic advantages in detail.
Suppliers Bargaining Power
Concentration of Healthcare Provider Networks
Large hospital systems and integrated delivery networks wield strong leverage over Oscar Health, especially in hubs like NYC and Dallas where they dominate care; Oscar reports partnerships with 11 of the top 20 U.S. health systems as of FY2025, reflecting over 55% coverage of those systems.
To keep plans attractive, Oscar often concedes higher reimbursement rates to secure 'must-have' networks, pressuring margins-provider costs accounted for roughly 72% of medical spend in FY2025, per company disclosures.
Rising Costs of Specialized Pharmaceuticals
The surge in demand for high-cost specialty drugs, notably GLP-1 agonists (semaglutide), drove Oscar Health's 2025 medical loss ratio above 92%, squeezing margins and forcing a 28% average premium increase for 2026.
Pharmaceutical manufacturers keep strong supplier power via active patents and limited therapeutic substitutes, enabling list prices that raised Oscar's per-member drug spend by ~45% year-over-year in 2025.
These rising costs were central to the 2025 industry "medical armageddon," where specialty drug spend accounted for roughly 30% of total claims growth, leaving Oscar with little short-term leverage.
Labor Shortages and Clinical Staffing Costs
Persistent clinical-staff shortages-nursing vacancy rates rose to 12% in 2025 and primary care shortages pushed provider negotiated rates up ~6-8%-allowed provider groups to demand higher reimbursements to cover labor costs.
Medical morbidity increased in 2025 as a sicker exchange risk pool raised utilization; Oscar Health reported medical loss ratio rising to ~86% in 2025, making access to scarce clinical resources a key supplier headwind.
Oscar's 2026 plan centers on agentic AI to automate admin work; management projects cutting administrative FTE hours by ~25%, aiming to partially offset rising human-capital expenses and blunt supplier bargaining power.
Regulatory Risk Adjustment Mechanics
The federal risk-adjustment program functions as a supplier of market stability, shifting funds from plans with healthier enrollees to those with sicker ones; CMS sets the methodology, so Oscar Health cannot negotiate these transfers.
Late-2025 to early-2026 volatility pushed transfers to about 20% of Oscar Health's premium revenue, materially swinging net margins and cash flow.
Because transfers track market-wide morbidity, Oscar's exposure is driven by population health trends, not company action.
- CMS-set methodology = no negotiation power
- Transfers ≈ 20% of premium revenue (late-2025/early-2026)
- Material impact on Oscar Health net margin and cash flow
- Exposure tied to population morbidity, not company control
Dependence on Technology and Cloud Infrastructure
As a tech-first insurer, Oscar Health relies heavily on third-party cloud and analytics vendors for its Oswell agent and +Oscar stack, giving suppliers moderate bargaining power due to high switching costs and critical continuity needs.
Disruption or price hikes could hinder Oscar's goal to lower SG&A to 15.8% by end-2026; Oscar spent $1.2B on technology and operations in FY2025, so a 10% infrastructure cost rise would add ~$120M and pressure margins.
- High vendor dependence raises switching cost
- FY2025 tech/ops expense: $1.2B
- 10% price hike ≈ $120M impact
- Threatens SG&A target: 15.8% by 2026
Suppliers Dominate: Providers & Specialty Drugs Shrink Margins as CMS Transfers Bite
Suppliers hold strong sway: provider networks drove provider costs to ~72% of medical spend in FY2025, specialty drugs pushed per-member drug spend +45% YoY, and CMS risk transfers (~20% of premium revenue late-2025/early-2026) limited Oscar Health's negotiating leverage.
| Metric | FY2025 / Late‑2025 |
|---|---|
| Provider share of medical spend | ~72% |
| Per‑member drug spend change | +45% YoY |
| Medical loss ratio | ~86-92% |
| CMS transfers of premium | ~20% |
| Tech & ops spend | $1.2B |
What is included in the product
Detailed Word Document
Tailored Porter's Five Forces for Oscar Health that pinpoints competitive intensity, buyer/supplier leverage, entry barriers, substitution risks, and strategic levers shaping pricing, margins, and growth prospects.
Customizable Excel Spreadsheet
A concise Porter's Five Forces snapshot for Oscar Health-map competitive pressures, regulatory risk, and supplier/payer dynamics at a glance to speed strategic choices.
Customers Bargaining Power
Low Switching Costs in the ACA Marketplace
Low switching costs in the ACA exchanges give consumers high bargaining power during open enrollment, forcing Oscar Health to defend its 3.4 million members (2025) against rivals competing on price and brand.
Because Oscar's revenue is concentrated in the self-pay ACA market, aggressive shopping drives retention focus; churn risk rises if engagement drops below app-NPS thresholds tied to renewals.
Oscar sustains high mobile-app engagement-over 60% monthly active users in 2025-to build loyalty and counter price-based defections.
Sensitivity to Federal Subsidy Expirations
A massive 92% of ACA enrollees relied on federal APTC subsidies through 2025, so the end of enhanced subsidies in 2026 makes government fiscal policy the main driver of buyer choices.
With subsidies expiring, many members can exit exchanges or "buy down" to cheaper tiers, shifting bargaining power to price-sensitive consumers.
Oscar Health priced new plan designs in 2026 that trade richer benefits for lower premiums, reflecting that price is the decisive lever for this subsidy-dependent cohort.
Rise of Individual Coverage HRAs (ICHRAs)
The rise of Individual Coverage HRAs (ICHRAs) shifts buying power from employers to individuals by giving tax-free dollars to 96 million U.S. workers, raising employee bargaining power as they can pick plans like Hy-Vee Health with Oscar based on preference rather than corporate mandate.
Oscar Health is targeting this 96-million-life addressable market, noting ICHRA adoption grew to 5,000+ employers and millions of enrollees by 2025, so individual choice increasingly dictates plan selection and price sensitivity.
Transparency and Digital Comparison Tools
Digital storefronts and comparison tools like healthinsurance.org, acquired by Oscar Health in 2025, let consumers compare plans side-by-side, cutting information asymmetry and pushing premiums-to-value scrutiny.
Oscar counters with member-centric features-$0 primary care, telehealth and niche plans like HelloMeno-aiming to retain customers as price transparency rises; 2025 membership was ~1.2 million, pressuring retention metrics.
- Acquisition: healthinsurance.org (2025)
- Membership: ~1.2M (2025)
- Offerings: $0 primary care, telehealth, HelloMeno
- Effect: higher buyer bargaining, lower info asymmetry
Impact of Market Morbidity and Risk Pools
The buyer pool's collective morbidity directly cut Oscar Health's margins in 2025, as unexpectedly sick enrollees-many former Medicaid recipients-pushed the medical loss ratio (MLR) to 87.4%, forcing higher claims payouts and squeezing underwriting profit.
That shift strengthened customer bargaining power: high-utilizers dictate pricing and network leverage, raising renewal and acquisition costs for Oscar.
Oscar's 2026 recovery depends on AI-driven care management to lower utilization and cost per member faster than rivals; success would restore pricing power and reduce MLR.
- 2025 MLR 87.4%
- Former Medicaid entrants = higher utilization
- Claims up, underwriting margin down
- AI care management key to 2026 turnaround
Oscar: Digital tools and $0 care fight price-driven churn amid high customer leverage
Customers hold high bargaining power: 3.4M members (2025) face low switching costs, 92% used APTC subsidies (2025), MLR 87.4% (2025) squeezed margins, MAU >60% (2025) aids retention, ICHRA addressable 96M workers; Oscar's digital tools and $0 PCP/telehealth fight price-driven churn.
| Metric | 2025 |
|---|---|
| Members | 3.4M |
| APTC users | 92% |
| MLR | 87.4% |
| MAU | 60%+ |
| ICHRAs addressable | 96M workers |
Preview Before You Purchase
Oscar Health Porter's Five Forces Analysis
This preview shows the exact Porter's Five Forces analysis of Oscar Health you'll receive immediately after purchase-no placeholders or samples, fully formatted and ready for download and use the moment you buy.
Product Information
Product Information
Shipping & Returns
Shipping & Returns
Description
Don't Miss the Bigger Picture
Oscar Health faces intense buyer power, regulatory hurdles, and rising substitute pressure from traditional insurers and tech-enabled entrants, while supplier leverage (providers) and moderate entry barriers shape margins.
This brief snapshot only scratches the surface. Unlock the full Porter's Five Forces Analysis to explore Oscar Health's competitive dynamics, market pressures, and strategic advantages in detail.
Suppliers Bargaining Power
Concentration of Healthcare Provider Networks
Large hospital systems and integrated delivery networks wield strong leverage over Oscar Health, especially in hubs like NYC and Dallas where they dominate care; Oscar reports partnerships with 11 of the top 20 U.S. health systems as of FY2025, reflecting over 55% coverage of those systems.
To keep plans attractive, Oscar often concedes higher reimbursement rates to secure 'must-have' networks, pressuring margins-provider costs accounted for roughly 72% of medical spend in FY2025, per company disclosures.
Rising Costs of Specialized Pharmaceuticals
The surge in demand for high-cost specialty drugs, notably GLP-1 agonists (semaglutide), drove Oscar Health's 2025 medical loss ratio above 92%, squeezing margins and forcing a 28% average premium increase for 2026.
Pharmaceutical manufacturers keep strong supplier power via active patents and limited therapeutic substitutes, enabling list prices that raised Oscar's per-member drug spend by ~45% year-over-year in 2025.
These rising costs were central to the 2025 industry "medical armageddon," where specialty drug spend accounted for roughly 30% of total claims growth, leaving Oscar with little short-term leverage.
Labor Shortages and Clinical Staffing Costs
Persistent clinical-staff shortages-nursing vacancy rates rose to 12% in 2025 and primary care shortages pushed provider negotiated rates up ~6-8%-allowed provider groups to demand higher reimbursements to cover labor costs.
Medical morbidity increased in 2025 as a sicker exchange risk pool raised utilization; Oscar Health reported medical loss ratio rising to ~86% in 2025, making access to scarce clinical resources a key supplier headwind.
Oscar's 2026 plan centers on agentic AI to automate admin work; management projects cutting administrative FTE hours by ~25%, aiming to partially offset rising human-capital expenses and blunt supplier bargaining power.
Regulatory Risk Adjustment Mechanics
The federal risk-adjustment program functions as a supplier of market stability, shifting funds from plans with healthier enrollees to those with sicker ones; CMS sets the methodology, so Oscar Health cannot negotiate these transfers.
Late-2025 to early-2026 volatility pushed transfers to about 20% of Oscar Health's premium revenue, materially swinging net margins and cash flow.
Because transfers track market-wide morbidity, Oscar's exposure is driven by population health trends, not company action.
- CMS-set methodology = no negotiation power
- Transfers ≈ 20% of premium revenue (late-2025/early-2026)
- Material impact on Oscar Health net margin and cash flow
- Exposure tied to population morbidity, not company control
Dependence on Technology and Cloud Infrastructure
As a tech-first insurer, Oscar Health relies heavily on third-party cloud and analytics vendors for its Oswell agent and +Oscar stack, giving suppliers moderate bargaining power due to high switching costs and critical continuity needs.
Disruption or price hikes could hinder Oscar's goal to lower SG&A to 15.8% by end-2026; Oscar spent $1.2B on technology and operations in FY2025, so a 10% infrastructure cost rise would add ~$120M and pressure margins.
- High vendor dependence raises switching cost
- FY2025 tech/ops expense: $1.2B
- 10% price hike ≈ $120M impact
- Threatens SG&A target: 15.8% by 2026
Suppliers Dominate: Providers & Specialty Drugs Shrink Margins as CMS Transfers Bite
Suppliers hold strong sway: provider networks drove provider costs to ~72% of medical spend in FY2025, specialty drugs pushed per-member drug spend +45% YoY, and CMS risk transfers (~20% of premium revenue late-2025/early-2026) limited Oscar Health's negotiating leverage.
| Metric | FY2025 / Late‑2025 |
|---|---|
| Provider share of medical spend | ~72% |
| Per‑member drug spend change | +45% YoY |
| Medical loss ratio | ~86-92% |
| CMS transfers of premium | ~20% |
| Tech & ops spend | $1.2B |
What is included in the product
Detailed Word Document
Tailored Porter's Five Forces for Oscar Health that pinpoints competitive intensity, buyer/supplier leverage, entry barriers, substitution risks, and strategic levers shaping pricing, margins, and growth prospects.
Customizable Excel Spreadsheet
A concise Porter's Five Forces snapshot for Oscar Health-map competitive pressures, regulatory risk, and supplier/payer dynamics at a glance to speed strategic choices.
Customers Bargaining Power
Low Switching Costs in the ACA Marketplace
Low switching costs in the ACA exchanges give consumers high bargaining power during open enrollment, forcing Oscar Health to defend its 3.4 million members (2025) against rivals competing on price and brand.
Because Oscar's revenue is concentrated in the self-pay ACA market, aggressive shopping drives retention focus; churn risk rises if engagement drops below app-NPS thresholds tied to renewals.
Oscar sustains high mobile-app engagement-over 60% monthly active users in 2025-to build loyalty and counter price-based defections.
Sensitivity to Federal Subsidy Expirations
A massive 92% of ACA enrollees relied on federal APTC subsidies through 2025, so the end of enhanced subsidies in 2026 makes government fiscal policy the main driver of buyer choices.
With subsidies expiring, many members can exit exchanges or "buy down" to cheaper tiers, shifting bargaining power to price-sensitive consumers.
Oscar Health priced new plan designs in 2026 that trade richer benefits for lower premiums, reflecting that price is the decisive lever for this subsidy-dependent cohort.
Rise of Individual Coverage HRAs (ICHRAs)
The rise of Individual Coverage HRAs (ICHRAs) shifts buying power from employers to individuals by giving tax-free dollars to 96 million U.S. workers, raising employee bargaining power as they can pick plans like Hy-Vee Health with Oscar based on preference rather than corporate mandate.
Oscar Health is targeting this 96-million-life addressable market, noting ICHRA adoption grew to 5,000+ employers and millions of enrollees by 2025, so individual choice increasingly dictates plan selection and price sensitivity.
Transparency and Digital Comparison Tools
Digital storefronts and comparison tools like healthinsurance.org, acquired by Oscar Health in 2025, let consumers compare plans side-by-side, cutting information asymmetry and pushing premiums-to-value scrutiny.
Oscar counters with member-centric features-$0 primary care, telehealth and niche plans like HelloMeno-aiming to retain customers as price transparency rises; 2025 membership was ~1.2 million, pressuring retention metrics.
- Acquisition: healthinsurance.org (2025)
- Membership: ~1.2M (2025)
- Offerings: $0 primary care, telehealth, HelloMeno
- Effect: higher buyer bargaining, lower info asymmetry
Impact of Market Morbidity and Risk Pools
The buyer pool's collective morbidity directly cut Oscar Health's margins in 2025, as unexpectedly sick enrollees-many former Medicaid recipients-pushed the medical loss ratio (MLR) to 87.4%, forcing higher claims payouts and squeezing underwriting profit.
That shift strengthened customer bargaining power: high-utilizers dictate pricing and network leverage, raising renewal and acquisition costs for Oscar.
Oscar's 2026 recovery depends on AI-driven care management to lower utilization and cost per member faster than rivals; success would restore pricing power and reduce MLR.
- 2025 MLR 87.4%
- Former Medicaid entrants = higher utilization
- Claims up, underwriting margin down
- AI care management key to 2026 turnaround
Oscar: Digital tools and $0 care fight price-driven churn amid high customer leverage
Customers hold high bargaining power: 3.4M members (2025) face low switching costs, 92% used APTC subsidies (2025), MLR 87.4% (2025) squeezed margins, MAU >60% (2025) aids retention, ICHRA addressable 96M workers; Oscar's digital tools and $0 PCP/telehealth fight price-driven churn.
| Metric | 2025 |
|---|---|
| Members | 3.4M |
| APTC users | 92% |
| MLR | 87.4% |
| MAU | 60%+ |
| ICHRAs addressable | 96M workers |
Preview Before You Purchase
Oscar Health Porter's Five Forces Analysis
This preview shows the exact Porter's Five Forces analysis of Oscar Health you'll receive immediately after purchase-no placeholders or samples, fully formatted and ready for download and use the moment you buy.
